| Financial Year |
March 31 2023 |
| Monetary Funds |
147,985,270.05 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,750,000.00 |
| Accounts Receivable |
1,073,873,924.04 |
| Advances to Suppliers |
16,035,692.49 |
| Other Receivables |
15,955,848.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
81,530,566.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,333,730.11 |
| Other Current Assets |
4,373,795.96 |
| Total Current Assets |
2,374,686,539.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
810,238.02 |
| Long-term Equity Investment |
22,912,555.32 |
| Investment Properties |
4,996,588.49 |
| Fixed Assetes |
24,137,737.53 |
| Under-construction Projects |
3,818,791.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,855,201.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,718,171.69 |
| Deferred Income Tax Assets |
90,699,622.03 |
| Other Non-Current Assets |
38,963,395.25 |
| Sub-Total of Non-Current Assets |
191,335,034.97 |
| Total Assets |
2,566,021,574.49 |
| Short-Term Loans |
301,301,757.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
90,726,887.99 |
| Accounts Payable |
774,704,912.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,963,411.62 |
| Taxes Payable |
129,352,028.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,498,105.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,224,201.64 |
| Other Current Liabilities |
57,695,661.06 |
| Sub-Total of Current Liabilities |
1,417,042,854.21 |
| Long-term Loans |
6,011,678.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
80,575.00 |
| Deferred Income Tax Liabilities |
27,436.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,253,399.10 |
| Total Liabilities |
1,423,296,253.31 |
| Paid-In Capital(Or Share Stock) |
105,600,000.00 |
| Capital Surplus |
485,118,718.31 |
| Surplus Reserve |
47,196,211.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
487,129,878.65 |
| Minority Stockholder's Interest |
17,561,895.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,125,163,425.20 |
| Owner's Equity（Stockholder's Equity） |
1,142,725,321.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,566,021,574.49 |
